Role of nasal nitric oxide in the resolution of experimental rhinovirus infection

Scherer P. Sanders, David Proud, Solbert Permutt, Edward S. Siekierski, Robin Yachechko, Mark Chang Hwa Liu

Research output: Contribution to journalArticle

Abstract

Background: Human rhinovirus (HRV) infections are associated with exacerbations of asthma, chronic obstructive pulmonary disease, and sinusitis. Nitric oxide (NO) might play an important role in host defense through its potent antiviral properties. Previous studies have shown that HRV infection in human subjects increased nasal epithelial expression of type 2 nitric oxide synthase (NOS2), an isoform of the enzyme that produces NO. Objective: We sought to investigate whether increases in exhaled NO (eNO) would accompany the increased NOS2 expression and would be associated with clearance of the virus. Methods: Six human subjects were infected with HRV-16 intranasally. eNO from nasal and lower airways was measured by means of direct measurement at multiple controlled flow rates. eNO was monitored at baseline (day 1) and on days 2 to 5, 8, 14, and 42 after infection. Nasal lavages were performed on days 1 to 5 and 8, and nasal scrapings were performed on days 1 to 4. NOS2 mRNA expression in nasal cells was measured by using quantitative real-time RT-PCR. Viral shedding in nasal lavage fluid was monitored by using real-time RT-PCR and bioassay. Results: Peak HRV titers and symptom scores were correlated on day 3, and HRV persisted until day 5 (n = 4) or day 8 (n = 2). Infection was associated with transient but significant increases in lymphocytes and monocytes in nasal lavage fluid. Significant increases in both nasal and lower airway eNO concentrations accompanied HRV infection and were positively correlated. Increased nasal eNO concentrations on day 3 were associated with increased expression of NOS2 mRNA in nasal scrapings. Symptom scores on day 4 were inversely correlated with the increases in nasal eNO concentration. Conclusions: We conclude that increased production of NO occurs as part of the host response to HRV infection and speculate that NO plays a beneficial role in viral clearance.

Original languageEnglish (US)
Pages (from-to)697-702
Number of pages6
JournalThe Journal of Allergy and Clinical Immunology
Volume113
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Rhinovirus
Nose
Nitric Oxide
Infection
Nasal Lavage Fluid
Real-Time Polymerase Chain Reaction
Nasal Lavage
Virus Shedding
Messenger RNA
Sinusitis
Nitric Oxide Synthase Type II
Biological Assay
Chronic Obstructive Pulmonary Disease
Antiviral Agents
Monocytes
Protein Isoforms
Asthma
Lymphocytes
Viruses

Keywords

  • Asthma
  • Common cold
  • Epithelial cells
  • Host defense
  • Inducible nitric oxide synthase
  • Nitric oxide
  • Rhinovirus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Role of nasal nitric oxide in the resolution of experimental rhinovirus infection. / Sanders, Scherer P.; Proud, David; Permutt, Solbert; Siekierski, Edward S.; Yachechko, Robin; Liu, Mark Chang Hwa.

In: The Journal of Allergy and Clinical Immunology, Vol. 113, No. 4, 04.2004, p. 697-702.

Research output: Contribution to journalArticle

Sanders, Scherer P. ; Proud, David ; Permutt, Solbert ; Siekierski, Edward S. ; Yachechko, Robin ; Liu, Mark Chang Hwa. / Role of nasal nitric oxide in the resolution of experimental rhinovirus infection. In: The Journal of Allergy and Clinical Immunology. 2004 ; Vol. 113, No. 4. pp. 697-702.
@article{8816543668bb40a8932abfcc7e0cf676,
title = "Role of nasal nitric oxide in the resolution of experimental rhinovirus infection",
abstract = "Background: Human rhinovirus (HRV) infections are associated with exacerbations of asthma, chronic obstructive pulmonary disease, and sinusitis. Nitric oxide (NO) might play an important role in host defense through its potent antiviral properties. Previous studies have shown that HRV infection in human subjects increased nasal epithelial expression of type 2 nitric oxide synthase (NOS2), an isoform of the enzyme that produces NO. Objective: We sought to investigate whether increases in exhaled NO (eNO) would accompany the increased NOS2 expression and would be associated with clearance of the virus. Methods: Six human subjects were infected with HRV-16 intranasally. eNO from nasal and lower airways was measured by means of direct measurement at multiple controlled flow rates. eNO was monitored at baseline (day 1) and on days 2 to 5, 8, 14, and 42 after infection. Nasal lavages were performed on days 1 to 5 and 8, and nasal scrapings were performed on days 1 to 4. NOS2 mRNA expression in nasal cells was measured by using quantitative real-time RT-PCR. Viral shedding in nasal lavage fluid was monitored by using real-time RT-PCR and bioassay. Results: Peak HRV titers and symptom scores were correlated on day 3, and HRV persisted until day 5 (n = 4) or day 8 (n = 2). Infection was associated with transient but significant increases in lymphocytes and monocytes in nasal lavage fluid. Significant increases in both nasal and lower airway eNO concentrations accompanied HRV infection and were positively correlated. Increased nasal eNO concentrations on day 3 were associated with increased expression of NOS2 mRNA in nasal scrapings. Symptom scores on day 4 were inversely correlated with the increases in nasal eNO concentration. Conclusions: We conclude that increased production of NO occurs as part of the host response to HRV infection and speculate that NO plays a beneficial role in viral clearance.",
keywords = "Asthma, Common cold, Epithelial cells, Host defense, Inducible nitric oxide synthase, Nitric oxide, Rhinovirus",
author = "Sanders, {Scherer P.} and David Proud and Solbert Permutt and Siekierski, {Edward S.} and Robin Yachechko and Liu, {Mark Chang Hwa}",
year = "2004",
month = "4",
doi = "10.1016/j.jaci.2004.01.755",
language = "English (US)",
volume = "113",
pages = "697--702",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Role of nasal nitric oxide in the resolution of experimental rhinovirus infection

AU - Sanders, Scherer P.

AU - Proud, David

AU - Permutt, Solbert

AU - Siekierski, Edward S.

AU - Yachechko, Robin

AU - Liu, Mark Chang Hwa

PY - 2004/4

Y1 - 2004/4

N2 - Background: Human rhinovirus (HRV) infections are associated with exacerbations of asthma, chronic obstructive pulmonary disease, and sinusitis. Nitric oxide (NO) might play an important role in host defense through its potent antiviral properties. Previous studies have shown that HRV infection in human subjects increased nasal epithelial expression of type 2 nitric oxide synthase (NOS2), an isoform of the enzyme that produces NO. Objective: We sought to investigate whether increases in exhaled NO (eNO) would accompany the increased NOS2 expression and would be associated with clearance of the virus. Methods: Six human subjects were infected with HRV-16 intranasally. eNO from nasal and lower airways was measured by means of direct measurement at multiple controlled flow rates. eNO was monitored at baseline (day 1) and on days 2 to 5, 8, 14, and 42 after infection. Nasal lavages were performed on days 1 to 5 and 8, and nasal scrapings were performed on days 1 to 4. NOS2 mRNA expression in nasal cells was measured by using quantitative real-time RT-PCR. Viral shedding in nasal lavage fluid was monitored by using real-time RT-PCR and bioassay. Results: Peak HRV titers and symptom scores were correlated on day 3, and HRV persisted until day 5 (n = 4) or day 8 (n = 2). Infection was associated with transient but significant increases in lymphocytes and monocytes in nasal lavage fluid. Significant increases in both nasal and lower airway eNO concentrations accompanied HRV infection and were positively correlated. Increased nasal eNO concentrations on day 3 were associated with increased expression of NOS2 mRNA in nasal scrapings. Symptom scores on day 4 were inversely correlated with the increases in nasal eNO concentration. Conclusions: We conclude that increased production of NO occurs as part of the host response to HRV infection and speculate that NO plays a beneficial role in viral clearance.

AB - Background: Human rhinovirus (HRV) infections are associated with exacerbations of asthma, chronic obstructive pulmonary disease, and sinusitis. Nitric oxide (NO) might play an important role in host defense through its potent antiviral properties. Previous studies have shown that HRV infection in human subjects increased nasal epithelial expression of type 2 nitric oxide synthase (NOS2), an isoform of the enzyme that produces NO. Objective: We sought to investigate whether increases in exhaled NO (eNO) would accompany the increased NOS2 expression and would be associated with clearance of the virus. Methods: Six human subjects were infected with HRV-16 intranasally. eNO from nasal and lower airways was measured by means of direct measurement at multiple controlled flow rates. eNO was monitored at baseline (day 1) and on days 2 to 5, 8, 14, and 42 after infection. Nasal lavages were performed on days 1 to 5 and 8, and nasal scrapings were performed on days 1 to 4. NOS2 mRNA expression in nasal cells was measured by using quantitative real-time RT-PCR. Viral shedding in nasal lavage fluid was monitored by using real-time RT-PCR and bioassay. Results: Peak HRV titers and symptom scores were correlated on day 3, and HRV persisted until day 5 (n = 4) or day 8 (n = 2). Infection was associated with transient but significant increases in lymphocytes and monocytes in nasal lavage fluid. Significant increases in both nasal and lower airway eNO concentrations accompanied HRV infection and were positively correlated. Increased nasal eNO concentrations on day 3 were associated with increased expression of NOS2 mRNA in nasal scrapings. Symptom scores on day 4 were inversely correlated with the increases in nasal eNO concentration. Conclusions: We conclude that increased production of NO occurs as part of the host response to HRV infection and speculate that NO plays a beneficial role in viral clearance.

KW - Asthma

KW - Common cold

KW - Epithelial cells

KW - Host defense

KW - Inducible nitric oxide synthase

KW - Nitric oxide

KW - Rhinovirus

UR - http://www.scopus.com/inward/record.url?scp=1942467837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942467837&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2004.01.755

DO - 10.1016/j.jaci.2004.01.755

M3 - Article

VL - 113

SP - 697

EP - 702

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 4

ER -